Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127881151 | 12788115 | 1 | I | 2005 | 20160916 | 20160928 | 20160928 | PER | US-ASTRAZENECA-2016SF00482 | ASTRAZENECA | 50.00 | YR | F | Y | 90.30000 | KG | 20160928 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127881151 | 12788115 | 1 | PS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 219300 | MG | Y | U | 22047 | 300 | MG | PROLONGED-RELEASE TABLET | QD | |||
127881151 | 12788115 | 2 | SS | SEROQUEL XR | QUETIAPINE FUMARATE | 1 | Oral | 219300 | MG | Y | U | 22047 | 300 | MG | PROLONGED-RELEASE TABLET | QD | |||
127881151 | 12788115 | 3 | C | MAVIK | TRANDOLAPRIL | 1 | Oral | 0 | 4 | MG | QD | ||||||||
127881151 | 12788115 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | 300 | MG | TID | ||||||||
127881151 | 12788115 | 5 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | GENERIC | 0 | 10 | MG | QD | |||||||
127881151 | 12788115 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 60 | MG | QD | ||||||||
127881151 | 12788115 | 7 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
127881151 | 12788115 | 8 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 0 | 100 | MG | QD | ||||||||
127881151 | 12788115 | 9 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | GENERIC | 0 | 10 | MG | QD | |||||||
127881151 | 12788115 | 10 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | QD | ||||||||
127881151 | 12788115 | 11 | C | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | GENERIC | 0 | 600 | MG | QD | |||||||
127881151 | 12788115 | 12 | C | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | GENERIC | 0 | 600 | MG | QD | |||||||
127881151 | 12788115 | 13 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0 | .5 | MG | QD | ||||||||
127881151 | 12788115 | 14 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0 | .5 | MG | QD | ||||||||
127881151 | 12788115 | 15 | C | REMERON | MIRTAZAPINE | 1 | Oral | 0 | 15 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127881151 | 12788115 | 1 | Bipolar disorder |
127881151 | 12788115 | 2 | Sleep disorder |
127881151 | 12788115 | 3 | Hypertension |
127881151 | 12788115 | 4 | Neuropathy peripheral |
127881151 | 12788115 | 5 | Multiple allergies |
127881151 | 12788115 | 6 | Depression |
127881151 | 12788115 | 7 | Depression |
127881151 | 12788115 | 8 | Bipolar disorder |
127881151 | 12788115 | 9 | Blood cholesterol abnormal |
127881151 | 12788115 | 10 | Sleep disorder |
127881151 | 12788115 | 11 | Sleep disorder |
127881151 | 12788115 | 12 | Bipolar disorder |
127881151 | 12788115 | 13 | Sleep disorder |
127881151 | 12788115 | 14 | Tardive dyskinesia |
127881151 | 12788115 | 15 | Sleep disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127881151 | 12788115 | Dyskinesia | |
127881151 | 12788115 | Off label use | |
127881151 | 12788115 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127881151 | 12788115 | 1 | 2005 | 0 | ||
127881151 | 12788115 | 2 | 2005 | 0 | ||
127881151 | 12788115 | 3 | 1996 | 0 | ||
127881151 | 12788115 | 4 | 1999 | 0 | ||
127881151 | 12788115 | 5 | 2013 | 0 | ||
127881151 | 12788115 | 6 | 2013 | 0 | ||
127881151 | 12788115 | 7 | 2012 | 0 | ||
127881151 | 12788115 | 8 | 2012 | 0 | ||
127881151 | 12788115 | 9 | 1991 | 0 | ||
127881151 | 12788115 | 10 | 2015 | 0 | ||
127881151 | 12788115 | 11 | 2015 | 0 | ||
127881151 | 12788115 | 12 | 2015 | 0 | ||
127881151 | 12788115 | 13 | 2014 | 0 | ||
127881151 | 12788115 | 14 | 2014 | 0 | ||
127881151 | 12788115 | 15 | 201603 | 0 |